Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload
Clinical trial NCT02435212 · COMPLETED
Trial details
- NCT number
- NCT02435212
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-21
- Primary completion
- 2018-05-31
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.